[RGLS] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
02-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -2.57%
YoY- -177.06%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 18 18 18 18 204 483 489 -88.91%
PBT -15,835 -21,736 -20,025 -20,015 -19,515 -21,098 -21,212 -17.69%
Tax -7 -128 -4 5 4 -8 -5 25.12%
NP -15,828 -21,608 -20,021 -20,020 -19,519 -21,090 -21,207 -17.70%
Tax Rate - - - - - - - -
Total Cost 15,846 21,626 20,039 20,038 19,723 21,573 21,696 -18.88%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin -87,933.33 -120,044.44 -111,227.78 -111,222.22 -9,568.14 -4,366.46 -4,336.81 642.21%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -21.09 -48.76 -45.34 -45.39 -44.33 -47.95 -48.28 -42.39%
EPS Diluted -21.09 -48.76 -45.34 -45.39 -44.33 -47.95 -48.28 -42.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.